Global MPNST registry aims to unlock secrets of rare nerve cancer

NCT ID NCT03141021

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study is building a worldwide database of people with malignant peripheral nerve sheath tumors (MPNST), a rare cancer often linked to the genetic condition neurofibromatosis type 1. Researchers will collect medical records, tumor samples, and genetic data to find patterns that could improve diagnosis and treatment. The goal is to better understand the disease, not to test a new therapy.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for MALIGNANT PERIPHERAL NERVE SHEATH TUMORS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Dana Farber Cancer Institute

    WITHDRAWN

    Boston, Massachusetts, 02215, United States

  • Global Gene Corporation

    COMPLETED

    Mumbai, India

  • Johns Hopkins

    RECRUITING

    Baltimore, Maryland, 21205, United States

  • Lifespan

    COMPLETED

    Providence, Rhode Island, 02903, United States

  • Memorial Sloan Kettering Cancer Center

    NOT_YET_RECRUITING

    New York, New York, 10065, United States

  • Moffitt Cancer Center

    COMPLETED

    Tampa, Florida, 33612, United States

  • Mount Sinai

    RECRUITING

    Toronto, Ontario, M5T 3L9, Canada

  • Nagoya University Hospital

    RECRUITING

    Nagoya, Showa Ward, Japan

  • National Institutes of Health (NIH)

    NOT_YET_RECRUITING

    Bethesda, Maryland, 20892, United States

  • Royal National Orthopedic Hospital

    TERMINATED

    London, United Kingdom

  • University of Minnesota

    WITHDRAWN

    Minneapolis, Minnesota, 55455, United States

  • University of Utah

    COMPLETED

    Salt Lake City, Utah, 84112, United States

  • Washington University School of Medicine

    RECRUITING

    St Louis, Missouri, 63110, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.